Sulfonylureas As 2nd-Line T2DM Therapy Tied to Higher Event Risk
Associated with increased risk of myocardial infarction, all-cause mortality, severe hypoglycemia
FDA Grants First Approval for CA Drug Under New Pilot Programs
Ribociclib approved in combo with AI as endocrine tx for HR-positive, HER2-negative advanced breast CA
VA MISSION Act May Up Costs, Lower Vet Health Care Quality
VA will have greater reliance on private sector care, which may not improve health status of veterans
CDC: More People With High Cholesterol Taking Medications
Findings only among men and women over 60 years, not younger patients with high cholesterol
Guidelines Conflict for Long-Term Opioid Tx in Cancer Survivors
Inconsistencies exist between CDC and NCCN opioid guideline recommendations
Medical Organizations Must Address Sexual Harassment
Proactive approach needed; should include interactive programs to get people talking
Monthly Vitamin D Supplement May Not Cut Cancer Risk
High-dose monthly supplementation doesn't reduce risk of cancer among middle-aged and older adults
Walmart Generic Drug Discounts Often Offer More Patient Savings
Walmart drug program offers savings over Medicare program for generic cardiovascular medications
FDA Approves Tibsovo for Acute Myeloid Leukemia
Approved for adults with relapsed or refractory acute myeloid leukemia who have IDH1 mutation
Empagliflozin Doesn’t Up Risk of Bone Fractures
Per pooled data from placebo-controlled trials and data from a head-to-head study with glimepiride
